Case Report
Accepted on 08 Jan 2025
Regenerative fibroblasts derived from autologous skin tissue for treatment of Sjögren's syndrome: a case report
Frontiers in Immunology
doi 10.3389/fimmu.2025.1529883
Volumes
112 Publications
Mini Review
Accepted on 08 Jan 2025
Assessing In-Vitro Models for Microglial Development and Fetal Programming: A Critical Review
Frontiers in Immunology
doi 10.3389/fimmu.2025.1538920
Original Research
Accepted on 08 Jan 2025
Atractylenolide-I Prevents Abdominal Aortic Aneurysm Formation Through Inhibiting Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1486072
Review
Accepted on 08 Jan 2025
A new weapon: the application of tumor vaccines based on extracellular exosomal heat shock proteins in immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1510650
Original Research
Accepted on 08 Jan 2025
The autoimmune disease risk variant NCF1-His90 is associated with a reduced risk of tuberculosis in women
Frontiers in Immunology
doi 10.3389/fimmu.2025.1514296
Case Report
Accepted on 08 Jan 2025
Sinonasal small cell carcinoma combined concurrently with small cell lung carcinoma: case report and literature review
Frontiers in Immunology
doi 10.3389/fimmu.2025.1457907
Review
Accepted on 07 Jan 2025
The success of the tumor immunotherapy: neutrophils from bench to beside
Frontiers in Immunology
doi 10.3389/fimmu.2025.1524038
Brief Research Report
Accepted on 07 Jan 2025
PDL1 inhibitors may be associated with a lower risk of allograft rejection than PD1 and CTLA4 inhibitors: analysis of the WHO pharmacovigilance database
Frontiers in Immunology
doi 10.3389/fimmu.2025.1514033
Original Research
Accepted on 07 Jan 2025
Dynamic Changes in Peripheral Blood Lymphocyte Trajectory Predict the Clinical Outcomes of Sepsis
Frontiers in Immunology
doi 10.3389/fimmu.2025.1431066
Original Research
Accepted on 07 Jan 2025
Efficacy of low-dose rituximab versus immunosuppressants in refractory orbital inflammatory pseudotumorspseudotumours with intracranial extension
Frontiers in Immunology
doi 10.3389/fimmu.2025.1516909
Original Research
Accepted on 07 Jan 2025
Comprehensive Single-Cell Pan-Cancer Atlas Unveils IFI30+ Macrophages as Key Modulators of Intra-tumoral Immune Dynamics
Frontiers in Immunology
doi 10.3389/fimmu.2025.1523854
Original Research
Accepted on 07 Jan 2025
SECTM1 acts as an immune-related biomarker of poor Prognosis and Promotes Cancer Progression by Modulating M2 macrophage polarization in esophageal squamous cell carcinoma
Frontiers in Immunology
doi 10.3389/fimmu.2025.1507227
Review
Accepted on 07 Jan 2025
Nanomaterials for liver cancer targeting: research progress and future prospects
Frontiers in Immunology
doi 10.3389/fimmu.2025.1496498
Original Research
Accepted on 07 Jan 2025
A preoperative predictive model based on multi-modal features to predict pathological complete response after neoadjuvant chemoimmunotherapy in esophageal cancer patients
Frontiers in Immunology
doi 10.3389/fimmu.2025.1530279
Original Research
Accepted on 07 Jan 2025
Establishment of a prognostic signature and immune infiltration characteristics for uterine corpus endometrial carcinoma based on a disulfidptosis/ferroptosis-associated signature
Frontiers in Immunology
doi 10.3389/fimmu.2025.1492541
Systematic Review
Accepted on 07 Jan 2025
Systematic review and quantitative meta-analysis of age-dependent human T-lymphocyte homeostasis
Frontiers in Immunology
doi 10.3389/fimmu.2025.1475871